Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Differentiated influenza vaccine (SK bioscience)
- Development stage
- Preclinical
- Lead developer
- SK bioscience
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Differentiated influenza vaccine is a preclinical-stage vaccine candidate being developed by SK bioscience for the prevention of influenza. It is positioned in the company's pipeline as a next-generation or "differentiated" product, distinct from their existing approved cell-culture-based vaccines, SKYCellflu 3-valent and 4-valent. The vaccine is designed to induce protective immunity against the influenza virus. While specific technical details regarding its differentiation—such as the use of a novel platform (e.g., mRNA or recombinant protein), increased valency, or the inclusion of an adjuvant—have not been fully disclosed, the project aims to address unmet needs in seasonal or pandemic influenza protection.
- Other names
- Differentiated influenza vaccine
02
Targets
Flu (Influenza surface proteins)
Beyond the preview
Go deeper on Differentiated influenza vaccine (SK bioscience).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Differentiated influenza vaccine (SK bioscience).